ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation

Chen, Xinhua; Zhao, Zean; Luo, Jiajun; Wu, Ting; Shen, Yudong; Chang, Shan; Wan, Shanhe; Li, Zhonghuang; Zhang, Jiajie*; Pang, Jianxin*; Tian, Yuanxin*华南农业大学; 南方医科大学; 江苏大学
Bioorganic Chemistry2021-12DOI: 10.1016/j.bioorg.2021.105444
6被引14阅读
引用收藏
分享

摘要

As a promising therapeutic target for gout, hURAT1 has attracted increasing attention. In this work, we identified a novel scaffold of hURAT1 inhibitors from a personal natural product database of verified herb-treated gout. First, we constructed more than 800 natural compounds from Chinese medicine that were verified to treat gout. Following the application of both shape-based and docking-based virtual screening (VS) methods, taking into account the shape similarity and flexibility of the target, we identified isopentenyl dihydroflavones that might inhibit hURAT1. Specifically, 9 compounds with commercial availability were tested with biochemical assays for the inhibition of C-14-uric acid uptake in high-expression hURAT1 cells (HEK293-hURAT1), and their structure-activity relationship was evaluated. As a result, 8-isopentenyl dihydroflavone was identified as a novel scaffold of hURAT1 inhibitors since isobavachin (DHF3) inhibited hURAT1 with an IC50 value of 0.39 +/- 0.17 mu M, which was comparable to verinurad with an IC50 value of 0.32 +/- 0.23 mu M. Remarkably, isobavachin also displayed an eminent effect in the decline of serum uric acid in vivo experiments. Taken together, isobavachin is a promising candidate for the treatment of hyperuricemia and gout.

学科与关键词

关键词
HyperuricemiaURAT1Virtual screeningIsoprenylated dihydroflavoneIsobavachin
相关
加载中…
  • Pharmacological evaluation of a novel skeleton compound isobavachin (4?,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity
    Zhao, Zean; Luo, Jian; Liao, Hui; Zheng, Fengxin; Chen, Xinhua; Luo, Jiajun; Chen, Yongjun; Zhao, Kunlu; Zhang, Shuqin; Tian, Jinhong; Wu, Ting; Li, Yongmei; Li, Lu; Yang, Yang; Lin, Cuiting; Zhang, Qun*; Tian, Yuanxin*; Pang, Jianxin*Bioorganic Chemistry, 2023, 133: 106405.被引 2
  • Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking
    Luo, Jia-jun; Chen, Xin-hua; Liang, Peng-ying; Zhao, Zean; Wu, Ting; Li, Zhong-huang; Wan, Shan-he; Luo, Jian; Pang, Jian-xin*; Zhang, Jia-jie*; Tian, Yuan-xin*Computers in Biology and Medicine, 2023, 155: 106637.
  • Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methods
    Zhu, XinYing; Yang, Chao; Zhang, Lei; Li, Jing*Journal of Molecular Structure, 2022, 1256: 132567.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2021-12
卷期
第 117 卷
页码
105444
DOI
10.1016/j.bioorg.2021.105444
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Foundation Science of China [81773794, 81974507]; Natural Science Foundation of Guangdong Province [2018A0303130088]

作者

  • C

    Chen, Xinhua (第一作者)

    new · southern med univ

  • Z

    Zhao, Zean

    new · southern med univ

查看全部 11 位作者收起作者
  • L

    Luo, Jiajun

    new · southern med univ

  • W

    Wu, Ting

    new · southern med univ

  • S

    Shen, Yudong

    south china agr univ

  • C

    Chang, Shan

    jiangsu univ

  • W

    Wan, Shanhe

    new · southern med univ

  • L

    Li, Zhonghuang

    new · southern med univ

  • Z

    Zhang, Jiajie (通讯)

    new · southern med univ

  • P

    Pang, Jianxin (通讯)

    new · southern med univ

  • T

    Tian, Yuanxin (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417